Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Braz. j. med. biol. res ; 40(10): 1339-1343, Oct. 2007. graf
Artigo em Inglês | LILACS | ID: lil-461358

RESUMO

In the present study, we investigated the in vitro anti-tumoral activities of fractions from aqueous extracts of the husk fiber of the typical A and common varieties of Cocos nucifera (Palmae). Cytotoxicity against leukemia cells was determined by the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay. Cells (2 x 104/well) were incubated with 0, 5, 50 or 500 æg/mL high- or low-molecular weight fractions for 48 h, treated with MTT and absorbance was measured with an ELISA reader. The results showed that both varieties have almost similar antitumoral activity against the leukemia cell line K562 (60.1 ± 8.5 and 47.5 ± 11.9 percent for the typical A and common varieties, respectively). Separation of the crude extracts with Amicon membranes yielded fractions with molecular weights ranging in size from 1-3 kDa (fraction A) to 3-10 kDa (fraction B) and to more than 10 kDa (fraction C). Cells were treated with 500 æg/mL of these fractions and cytotoxicity was evaluated by MTT. Fractions ranging in molecular weight from 1-10 kDa had higher cytotoxicity. Interestingly, C. nucifera extracts were also active against Lucena 1, a multidrug-resistant leukemia cell line. Their cytotoxicity against this cell line was about 50 percent (51.9 ± 3.2 and 56.3 ± 2.9 for varieties typical A and common, respectively). Since the common C. nucifera variety is extensively cultured in Brazil and the husk fiber is its industrial by-product, the results obtained in the present study suggest that it might be a very inexpensive source of new antineoplastic and anti-multidrug resistant drugs that warrants further investigation.


Assuntos
Humanos , Antineoplásicos Fitogênicos/farmacologia , Cocos/química , Extratos Vegetais/farmacologia , Ensaios de Seleção de Medicamentos Antitumorais , Resistencia a Medicamentos Antineoplásicos/efeitos dos fármacos , /efeitos dos fármacos
2.
Braz J Med Biol Res ; 40(10): 1339-43, 2007 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-17713650

RESUMO

In the present study, we investigated the in vitro anti-tumoral activities of fractions from aqueous extracts of the husk fiber of the typical A and common varieties of Cocos nucifera (Palmae). Cytotoxicity against leukemia cells was determined by the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay. Cells (2 x 10(4)/well) were incubated with 0, 5, 50 or 500 microg/mL high- or low-molecular weight fractions for 48 h, treated with MTT and absorbance was measured with an ELISA reader. The results showed that both varieties have almost similar antitumoral activity against the leukemia cell line K562 (60.1 +/- 8.5 and 47.5 +/- 11.9% for the typical A and common varieties, respectively). Separation of the crude extracts with Amicon membranes yielded fractions with molecular weights ranging in size from 1-3 kDa (fraction A) to 3-10 kDa (fraction B) and to more than 10 kDa (fraction C). Cells were treated with 500 microg/mL of these fractions and cytotoxicity was evaluated by MTT. Fractions ranging in molecular weight from 1-10 kDa had higher cytotoxicity. Interestingly, C. nucifera extracts were also active against Lucena 1, a multidrug-resistant leukemia cell line. Their cytotoxicity against this cell line was about 50% (51.9 +/- 3.2 and 56.3 +/- 2.9 for varieties typical A and common, respectively). Since the common C. nucifera variety is extensively cultured in Brazil and the husk fiber is its industrial by-product, the results obtained in the present study suggest that it might be a very inexpensive source of new antineoplastic and anti-multidrug resistant drugs that warrants further investigation.


Assuntos
Antineoplásicos Fitogênicos/farmacologia , Cocos/química , Extratos Vegetais/farmacologia , Resistencia a Medicamentos Antineoplásicos/efeitos dos fármacos , Ensaios de Seleção de Medicamentos Antitumorais , Humanos , Células K562/efeitos dos fármacos
3.
Invest New Drugs ; 25(6): 525-33, 2007 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17520174

RESUMO

Pomolic acid (PA) is a pentacyclic triterpene which has been previously described as active in inhibiting the growth of K562 cell line-originated from chronic myeloid leukemia (CML) in blast crisis-and its vincristine-resistant derivative K562-Lucena1. In this work, cells from CML patients were treated with PA and the apoptotic index was compared with the multidrug resistance (MDR) profile and clinical status of the patients. Our findings show that PA 12.5 microg/ml at 24 h (p = 0.000), at 48 h (p = 0.012) and at 72 h (p = 0.005) has a potent apoptotic index in CML cells as compared to mononuclear cells from healthy donors. PA was capable to induce apoptosis in cells from CML patients exhibiting functional MDR phenotype but not in P-glycoprotein expression. In addition, PA was effective in chronic as well as in blast phase of CML. Moreover, similar apoptotic index induced by PA was observed in low, intermediate and high-risk Sokal score as well as in samples from the group of patients with clinical resistance to interferon and/or imatinib and non-treated patients. These results suggest that PA may be an effective agent for the treatment of CML.


Assuntos
Antineoplásicos/farmacologia , Apoptose/efeitos dos fármacos , Resistencia a Medicamentos Antineoplásicos , Leucemia Mielogênica Crônica BCR-ABL Positiva/tratamento farmacológico , Ácido Oleanólico/análogos & derivados , Antineoplásicos/administração & dosagem , Antineoplásicos/uso terapêutico , Crise Blástica/tratamento farmacológico , Crise Blástica/patologia , Resistência a Múltiplos Medicamentos , Humanos , Leucemia Mielogênica Crônica BCR-ABL Positiva/patologia , Leucemia Mieloide de Fase Acelerada/tratamento farmacológico , Leucemia Mieloide de Fase Acelerada/patologia , Leucemia Mieloide de Fase Crônica/tratamento farmacológico , Leucemia Mieloide de Fase Crônica/patologia , Ácido Oleanólico/administração & dosagem , Ácido Oleanólico/farmacologia , Ácido Oleanólico/uso terapêutico
4.
Cancer Lett ; 248(1): 147-52, 2007 Apr 08.
Artigo em Inglês | MEDLINE | ID: mdl-16889888

RESUMO

The effects of oleanolic acid (OA) on ABCB1 and ABCC1 activities were studied in a cell line constitutively expressing both proteins. It was observed that OA did not alter ABCB1 activity, but inhibited the activity of ABCC1 protein. This inhibition was reversible and only occurred in the presence of OA. In addition, OA did not alter the expression of ABCC1 mRNA. These results suggest that OA could be a good choice in the treatment of MDR tumours, either as a chemotherapic itself in tumours bearing ABCB1, or as an adjuvant in the chemotherapy of ABCC1 expressing tumours.


Assuntos
Membro 1 da Subfamília B de Cassetes de Ligação de ATP/genética , Proteínas Associadas à Resistência a Múltiplos Medicamentos/genética , Ácido Oleanólico/farmacologia , Membro 1 da Subfamília B de Cassetes de Ligação de ATP/metabolismo , Animais , Antineoplásicos/farmacologia , Linhagem Celular , Sobrevivência Celular/efeitos dos fármacos , Relação Dose-Resposta a Droga , Citometria de Fluxo , Expressão Gênica/efeitos dos fármacos , Proteínas Associadas à Resistência a Múltiplos Medicamentos/metabolismo , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa
5.
Rev. bras. farmacogn ; 14(supl): 11-14, 2004. graf, tab
Artigo em Português | LILACS | ID: lil-570858

RESUMO

O presente trabalho avaliou as atividades antinociceptiva e antiinflamatória do óleo essencial de cascas de Duguetia lanceolata. Para isto, foram realizados os testes de contorções abdominais induzidas por ácido acético; tempo da lambida da pata induzida por formalina; e edema de pata induzido por carragenina. O número de contorções abdominais (DE50 = 21,79 mg/kg) e o tempo da lambida da pata 1ª fase (DE50 = 5,27 mg/kg) e 2ª fase (DE50 = 1,43 mg/ kg) foram reduzidos significativamente de forma dependente da dose. O material vegetal nas doses de 50, 100 e 200 mg/kg diminuíram de maneira expressiva o edema de pata em 20,83; 36,46 e 48,96 por cento, respectivamente. O óleo essencial de cascas de D. lanceolata possui efeitos antinociceptivo e antiinflamatório por prováveis ações central e periférica.


The present work evaluated the antinociceptive and anti-inflammatory activities of the essential oil from barks of Duguetia lanceolata. For this purpose, acetic acid writhing, formalin and carrageenan tests were performed. The number of writhings (ED50 = 21,79 mg/kg) and the lick of the paw 1st phase (ED50 = 5,27 mg/kg) e 2nd phase (ED50 = 1,43 mg/kg) reduced significantly in a dosedependent form. The doses 50, 100 and 200 mg/kg reduced the paw edema significantly in 20,83; 36,46 and 48,96 percent, respectively. These results suggest that the essential oil from barks of D. lanceolata has antinociceptive and anti-inflammatory effects and probably the mechanisms(s) involve central and peripheric actions.

6.
J Immunol ; 164(4): 2001-8, 2000 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-10657651

RESUMO

Recent studies indicate important roles for CTLA-4 engagement in T cells, and for TGF-beta production in the immunopathogenesis of murine kalaazar or visceral leishmaniasis, but a functional link between these two pathways in helping intracellular parasite growth is unknown. Here we report that Ag or anti-CD3 activation of splenic CD4+ T cells from visceral leishmaniasis leads to intense CTLA-4-mediated TGF-beta1 production, as assessed either by CTLA-4 blockade or by direct CTLA-4 cross-linkage. Production of TGF-beta1 accounted for the reciprocal regulation of IFN-gamma production by CTLA-4 engagement. Following CD4+ T cell activation, intracellular growth of Leishmania chagasi in cocultured splenic macrophages required both CTLA-4 function and TGF-beta1 secretion. Cross-linkage of CTLA-4 markedly increased L. chagasi replication in cocultures of infected macrophages and activated CD4+ T cells, and parasite growth could be completely blocked with neutralizing anti-TGF-beta1 Ab. Exogenous addition of rTGF-beta1 restored parasite growth in cultures protected from parasitism by CTLA-4 blockade. These results indicate that the negative costimulatory receptor CTLA-4 is critically involved in TGF-beta production and in intracellular parasite replication seen in murine kalaazar.


Assuntos
Adjuvantes Imunológicos/fisiologia , Antígenos de Diferenciação/fisiologia , Imunoconjugados , Imunossupressores/farmacologia , Leishmaniose Visceral/imunologia , Fator de Crescimento Transformador beta/fisiologia , Abatacepte , Animais , Antígenos CD , Antígenos de Diferenciação/imunologia , Antígenos de Diferenciação/metabolismo , Linfócitos T CD4-Positivos/imunologia , Linfócitos T CD4-Positivos/metabolismo , Linfócitos T CD4-Positivos/parasitologia , Antígeno CTLA-4 , Células Cultivadas , Epitopos de Linfócito T/imunologia , Feminino , Soros Imunes/farmacologia , Imunidade Celular/imunologia , Leishmania infantum/crescimento & desenvolvimento , Leishmania infantum/imunologia , Leishmaniose Visceral/parasitologia , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Fator de Crescimento Transformador beta/metabolismo
7.
Parasitology ; 117 ( Pt 5): 483-90, 1998 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-9836313

RESUMO

We compared a Trypanosoma cruzi clone unable to infect or induce pathology in mice (CL-14), with virulent T. cruzi (Y and CL strains) in terms of cruzipain expression, subcellular distribution and functional activity. Our results showed that (1) intracellular Y amastigotes expressed R1 (carboxy-terminal) and R2 (catalytic) domains concentrated in cytoplasmic vesicles, while CL-14 presented R1 labelling on membrane clusters and R2 in intracellular compartments, (2) CL-14-trypomastigotes presented R1 and R2 staining preferentially on flagellar and cellular membranes, similar to CL, but different from Y strain intracellular labelling pattern, (3) flow-cytometry revealed higher expression of R1 by CL-14-trypomastigotes than virulent strains, but R2 staining similar to CL-trypomastigotes, (4) CL-14-trypomastigotes presented normal cruzipain activity in gelatin gels, but different banding patterns were found in CL-14 versus CL and Y strains. Our data rule out failure in cruzipain expression, activity or subcellular distribution as an explanation for CL-14 biological behaviour, but suggest the expression of a different isoform. These results also cast doubt on the putative role of cruzipain as a target of immunopathological responses, since high levels of functional cruzipain are expressed by a non-pathogenic T. cruzi.


Assuntos
Antígenos de Protozoários/análise , Cisteína Endopeptidases/análise , Trypanosoma cruzi/enzimologia , Animais , Eletroforese em Gel de Poliacrilamida , Citometria de Fluxo , Imuno-Histoquímica , Camundongos , Proteínas de Protozoários , Trypanosoma cruzi/química , Trypanosoma cruzi/imunologia
8.
J Exp Med ; 179(4): 1373-8, 1994 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-8145049

RESUMO

Interferon gamma-inducible protein 10 (IP-10), a member of a family of small proinflammatory chemotactic polypeptides, is expressed in interferon gamma-stimulated keratinocytes, macrophages, fibroblasts, and endothelial cells. Here we report that IP-10 is also expressed by activated but not resting T hybridoma cells, normal T cells, and thymocytes. Although resting lymphocytes did not synthesize IP-10, surprisingly high levels of IP-10 transcripts were found in lymphoid organs (spleen, thymus, and lymph nodes). Thymic and splenic stromal cells were found to express constitutively high levels of both IP-10 mRNA and protein, accounting for the high level of spontaneous expression in lymphoid tissue. Therefore, in addition to its role as a proinflammatory cytokine, IP-10 may participate in T cell effector function and perhaps T cell development.


Assuntos
Quimiocinas CXC , Citocinas/biossíntese , Interferon gama/fisiologia , Tecido Linfoide/metabolismo , Linfócitos T/metabolismo , Timo/metabolismo , Animais , Quimiocina CXCL10 , Citocinas/genética , Hibridomas , Camundongos , Timo/citologia , Transcrição Gênica
9.
J Med Vet Mycol ; 26(2): 105-11, 1988 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-2971102

RESUMO

Seventy untreated paracoccidioidomycosis patients, 15 with the acute or subacute form of the disease and 55 with the chronic form, were compared with two normal control groups of the same age range. Peripheral blood mononuclear cell subsets were defined by monoclonal antibodies directed at total T cells, helper/inducer and suppressor/cytotoxic T cell subpopulations; B cells, cortical thymocytes and monocyte/null cells. Both groups of patients showed an increased number of monocyte/null cells, a low helper/suppressor ratio and a reduced percentage of total T cells and their helper/inducer subsets. In addition patients with the acute form of the disease exhibited high levels of suppressor/cytotoxic T cells and B cells. These findings are of importance in our attempts to understand the pathogenesis of this mycosis and also to evaluate its prognosis in individual patients.


Assuntos
Leucócitos Mononucleares , Paracoccidioidomicose/imunologia , Adolescente , Adulto , Idoso , Antígenos de Diferenciação de Linfócitos T/imunologia , Feminino , Humanos , Imunidade Celular , Células Matadoras Naturais , Contagem de Leucócitos , Masculino , Pessoa de Meia-Idade , Linfócitos T Auxiliares-Indutores , Linfócitos T Reguladores
10.
Braz J Med Biol Res ; 16(3): 227-33, 1983 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-6360266

RESUMO

The cell types present in the crescents were studied in 5 human patients with crescentic glomerulonephritis: two cases of systemic lupus erythematosus, one case of hemolytic uremic syndrome and two cases of rapidly progressive glomerulonephritis. Frozen sections of renal biopsies were studied by immunofluorescence, using murine monoclonal antibodies (orthoclones) against specific antigens on the membrane of human peripheral blood cells, and by histochemical methods. Monocytes (OKM1+, OKIa+ cells) but no lymphocytes (OKT+ cells), were detected in the crescentic glomeruli. Subsets of T lymphocytes (inducer-helper and cytotoxic-suppressor) were detected in the interstitium. Non-specific esterase-positive cells were observed in the glomeruli and in small numbers in the crescents. Fibrinogen deposits were present in the crescents of four of the five cases studied. No immunoglobulins (IgG, IgM, IgA) or complement (C1q, C3) deposits were detected in the crescents. Fibrinogen, immunoglobulins and complement were present in the glomerular tufts.


Assuntos
Glomerulonefrite/patologia , Macrófagos/patologia , Monócitos/patologia , Anticorpos Monoclonais , Esterases/metabolismo , Imunofluorescência , Secções Congeladas , Glomerulonefrite/imunologia , Humanos , Macrófagos/enzimologia , Linfócitos T/patologia
11.
N Engl J Med ; 307(26): 1593-7, 1982 Dec 23.
Artigo em Inglês | MEDLINE | ID: mdl-6216407

RESUMO

We report on the characteristics of cells in the cutaneous lesions and blood of 21 patients with lepromatous, tuberculoid, and intermediate forms of leprosy. A large proportion of the infiltrates in lepromatous lesions consist of macrophages heavily parasitized with Mycobacterium leprae. The T cells in the lesions are devoid of OKT4/Leu 3a-positive ("helper") cells and consist almost exclusively of OKT8/Leu 2a-positive ("suppressor") populations. In contrast, the tuberculoid infiltrates contain well-organized epithelioid and giant-cell granulomas and only remnants of bacilli, and the predominant T cell is from the OKT4/Leu 3a-positive subset. In both tuberculoid and lepromatous infiltrates, T cells and macrophages expressed HLA-DR antigen. No marked alteration in the distribution of blood T-cell phenotypes was noted. We conclude that there is a marked difference between T-cell subsets in lepromatous and tuberculoid infiltrates, which may influence the microbicidal activity of macrophages in the lesions.


Assuntos
Hanseníase/patologia , Pele/patologia , Linfócitos T/imunologia , Anticorpos Monoclonais/imunologia , Imunofluorescência , Antígenos HLA-DR , Antígenos de Histocompatibilidade Classe II/análise , Humanos , Hanseníase/sangue , Hanseníase/imunologia , Macrófagos/imunologia , Macrófagos/microbiologia , Mycobacterium leprae/isolamento & purificação , Fenótipo , Pele/ultraestrutura , Linfócitos T Auxiliares-Indutores/imunologia , Linfócitos T Reguladores/imunologia
13.
Biochim Biophys Acta ; 389(3): 506-15, 1975 May 21.
Artigo em Inglês | MEDLINE | ID: mdl-804935

RESUMO

Effects of Na+ and K+ on Ca-2+ transport by sarcoplasmic reticulum vesicles were studied in a medium containing high Mg-2+ and ATP (2mM) and low Ca-2+ (0.44muM) concentrations. Under these conditions, Na+ and K+ inhibit Ca-2+ uptake, ATPase activity and membrane phosphorylation by ATP. Since the concentrations of ATP and Ca-2+ used are consistent with relaxation in vivo, the results suggest that under physiological resting conditions the Ca-2+ pump of the sarcoplasmic reticulum operates below its maximal capacity.


Assuntos
Cálcio/metabolismo , Potássio/farmacologia , Retículo Sarcoplasmático/metabolismo , Sódio/farmacologia , Trifosfato de Adenosina/metabolismo , Animais , Transporte Biológico , Cálcio/farmacologia , Ácido Egtázico/farmacologia , Técnicas In Vitro , Cinética , Lítio/farmacologia , Músculos/metabolismo , Concentração Osmolar , Coelhos , Retículo Sarcoplasmático/efeitos dos fármacos , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA